These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21976507)

  • 1. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry.
    Hays SA; Huber KM; Gibson JR
    J Neurosci; 2011 Oct; 31(40):14223-34. PubMed ID: 21976507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
    Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
    J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
    Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.
    Gibson JR; Bartley AF; Hays SA; Huber KM
    J Neurophysiol; 2008 Nov; 100(5):2615-26. PubMed ID: 18784272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
    Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
    Ronesi JA; Collins KA; Hays SA; Tsai NP; Guo W; Birnbaum SG; Hu JH; Worley PF; Gibson JR; Huber KM
    Nat Neurosci; 2012 Jan; 15(3):431-40, S1. PubMed ID: 22267161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice.
    Wilson BM; Cox CL
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2454-9. PubMed ID: 17287348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postnatal plasticity in neocortex of Fmr1 knockout mice.
    Desai NS; Casimiro TM; Gruber SM; Vanderklish PW
    J Neurophysiol; 2006 Oct; 96(4):1734-45. PubMed ID: 16823030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
    Niere F; Wilkerson JR; Huber KM
    J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
    Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
    Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR.
    Price TJ; Rashid MH; Millecamps M; Sanoja R; Entrena JM; Cervero F
    J Neurosci; 2007 Dec; 27(51):13958-67. PubMed ID: 18094233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
    Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
    Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postsynaptic FMRP promotes the pruning of cell-to-cell connections among pyramidal neurons in the L5A neocortical network.
    Patel AB; Loerwald KW; Huber KM; Gibson JR
    J Neurosci; 2014 Feb; 34(9):3413-8. PubMed ID: 24573297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.
    Lovelace JW; Rais M; Palacios AR; Shuai XS; Bishay S; Popa O; Pirbhoy PS; Binder DK; Nelson DL; Ethell IM; Razak KA
    Cereb Cortex; 2020 Mar; 30(3):969-988. PubMed ID: 31364704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
    Osterweil EK; Krueger DD; Reinhold K; Bear MF
    J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female-specific dysfunction of sensory neocortical circuits in a mouse model of autism mediated by mGluR5 and estrogen receptor α.
    Molinaro G; Bowles JE; Croom K; Gonzalez D; Mirjafary S; Birnbaum SG; Razak KA; Gibson JR; Huber KM
    Cell Rep; 2024 Apr; 43(4):114056. PubMed ID: 38581678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Sleep Architecture and Hippocampal Circuit Dysfunction in a Mouse Model of Fragile X Syndrome.
    Boone CE; Davoudi H; Harrold JB; Foster DJ
    Neuroscience; 2018 Aug; 384():275-289. PubMed ID: 29775702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
    Yan QJ; Rammal M; Tranfaglia M; Bauchwitz RP
    Neuropharmacology; 2005 Dec; 49(7):1053-66. PubMed ID: 16054174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.